![](/img/cover-not-exists.png)
Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis
Ryan, P, McBride, A, Ray, D, Pulgar, S, Ramirez, RA, Elquza, E, Favaro, JP, Dranitsaris, GLanguage:
english
Journal:
Journal of Oncology Pharmacy Practice
DOI:
10.1177/1078155219839458
Date:
March, 2019
File:
PDF, 309 KB
english, 2019